Neogen Chemicals Limited upgraded its standalone revenue guidance for FY27 to ₹950-1,050 crore from the earlier range of ₹875-950 crore, driven by record quarterly revenues in its organo-lithium and battery chemicals portfolios. The company reported a 67% year-on-year surge in consolidated net profit after tax (PAT) to ₹17 crore for Q1FY27, while consolidated revenue rose 34% to ₹250 crore. To support its aggressive expansion into battery materials and de-leverage its balance sheet, the Board of Directors approved raising up to ₹600 crore through a Qualified Institutional Placement (QIP), subject to regulatory approvals.

The financial results were approved by the Board on July 26, 2026, and reviewed by Statutory Auditors Chandabhoy & Jassoobhoy. During the earnings conference call held on July 27, 2026, Managing Director Dr. Harin Kanani and Chief Financial Officer Gopikrishnan Sarathy highlighted that the strong performance was achieved despite headwinds from the Dahej plant reconstruction and geopolitical freight spikes. The company successfully implemented cost pass-through mechanisms for raw materials, utilities, and freight to protect operating margins.

Financial Performance and Segment Growth

Consolidated EBITDA grew 53% to ₹48 crore, with margins expanding by 260 basis points to 19.3%. Gross profit increased by 37% to ₹117 crore. On a standalone basis, revenue reached ₹252.30 crore, up 37% year-on-year, with net profit rising 37% to ₹19.44 crore. Standalone EBITDA was ₹48.20 crore, reflecting a margin expansion of 30 basis points to 19.1%. Interest expenses rose 65% to ₹23.10 crore due to higher debt servicing costs associated with capital expenditure at Neogen Ionics Limited.

The growth was anchored by robust volume increases across core verticals. Organic chemicals revenue grew 18% to ₹194 crore, while the inorganic chemicals segment surged 158% to ₹57 crore. Neogen Ionics Limited contributed significantly, generating ₹19 crore in revenue compared to ₹5 crore in Q1FY26, representing over 50% of the subsidiary’s entire prior-year revenue in a single quarter.

Strategic Expansion and Capital Allocation

Neogen Chemicals is accelerating its footprint in the lithium-ion battery sector through Neogen Ionics Limited. The Dahej replacement plant reconstruction is nearly complete, with commercial production expected to commence in Q2FY27. Cumulative insurance recoveries stand at ₹164 crore, with a net claim receivable of ₹186 crore pending final settlement.

For FY27, the company expects battery chemical revenue to reach approximately ₹300 crore, comprising ₹200 crore from salts and ₹100 crore from electrolytes. Dr. Kanani noted that US customers are shifting to non-FEOC (Foreign Entity of Concern) suppliers starting January 2027, driving demand for Neogen’s Japanese-backed technology. The company has secured provisional approvals from four international customers for lithium electrolyte salts and completed site audits with all four electrolyte manufacturers.

The proposed ₹600 crore QIP will primarily be used for debt reduction, aiming to lower annual interest costs by ₹40-50 crore if fully utilized. This deleveraging strategy positions the company to capture future growth opportunities, including potential expansions in salt capacity and R&D investments in novel battery additives.

What the Numbers Show

The divergence between standalone and consolidated metrics underscores the strategic pivot toward high-margin battery materials. While standalone operations delivered steady growth, the consolidated EBITDA surge of 53% versus standalone’s 39% indicates that Neogen Ionics is beginning to offset transitional costs at the core chemical business. The 65% rise in interest expenses highlights the leverage required to fund this expansion, making the timely execution of the QIP crucial for balance sheet health. With the Dahej plant nearing completion and trial runs underway, the normalization of core operations combined with scaling battery materials output positions Neogen Chemicals for significant operating leverage in FY27.

Neogen Chemicals Limited has scheduled its 37th Annual General Meeting (AGM) for Friday, August 21, 2026, at 5:00 p.m. IST, to be conducted via video conferencing and Other Audio-Visual Means (OAVM). The meeting is critical for shareholders as it includes voting on a special resolution to raise up to ₹600 crore through a Qualified Institutional Placement (QIP), alongside the approval of the final dividend for FY25-26. Investors must hold shares as of the record date, Thursday, August 13, 2026, to be eligible for both the dividend payout and voting rights.

The Register of Members and Share Transfer Register will remain closed from Friday, August 14, 2026, to Friday, August 21, 2026. This closure period prevents share transfers during the eligibility determination phase. The company’s Board of Directors has recommended a final dividend of Re 1 per equity share of ₹10 face value. Shareholders are advised to update their bank details immediately to ensure electronic dividend receipt; those without updated details will receive physical warrants. Additionally, residents must submit tax exemption declarations under the Income Tax Act by August 13, 2026, if their expected dividend exceeds ₹10,000 in FY26-27, to avoid Tax Deduction at Source (TDS).

E-Voting and Participation Details

The company has appointed MUGF Intime India Private Limited (formerly Link Intime India Private Limited) as its Registrar and Transfer Agent (RTA). Remote e-voting will commence on Tuesday, August 18, 2026, at 9:00 a.m. IST and conclude on Thursday, August 20, 2026, at 5:00 p.m. IST. Once a vote is cast remotely, it cannot be changed. During the AGM on August 21, members who have not voted remotely can cast their votes electronically within 30 minutes of the meeting's conclusion.

Shareholders wishing to speak at the meeting must register as speakers by emailing investor@neogenchem.com from their registered email ID by 5:00 p.m. on Thursday, August 20, 2026. Technical support for the Instameet login and e-voting platform is available via instameet@in.mpms.mufg.com or by calling 022-4918 6000 / 4918 6175.

Capital Raise and Governance Resolutions

The proposed QIP aims to raise funds for capital expenditure, debt repayment, business expansion, and general corporate purposes. Under SEBI ICDR Regulations, at least 10% of eligible securities must be allotted to Mutual Funds, and no single allottee can hold more than 50% of the issue size. The Board retains authority to determine pricing and timing, subject to regulatory approvals.

Other key resolutions include the re-appointment of Dr. Harin Kanani as Managing Director and the ratification of remuneration for Kishore Bhatia & Associates as Cost Auditors for FY26-27 at ₹4,75,000 plus taxes. Mr. Devendra Deshpande of DVD & Associates has been appointed as the Scrutinizer to ensure a fair and transparent e-voting process. The Integrated Annual Report and AGM Notice are available on the company’s website and stock exchange portals.